From: Computational assembly of a human Cytomegalovirus vaccine upon experimental epitope legacy
Epitope | Antigen gene | a Accession number | b PDB | c Flexibility | d Accessibility (%) |
---|---|---|---|---|---|
VSIDDDTPML | UL75 | Q6SW67 | 5VOB: A [238–247] | 0.131 | 25.37 |
TNQYLIKGISYPVST | UL75 | Q6SW67 | 5VOB: A [592–606] | 0.09 | 32.63 |
AFHLLLNTYGR | UL75 | Q6SW67 | 5VOB: A [37–47] | 1.618 | 55.08 |
IFTEHVLGFELVPPS | UL115 | F5HCH8 | 5VOB: B [173–187] | −0.275 | 11.71 |
TANQNPSPPWSKLTYSKPH | UL130 | F5HCP3 | 5VOB: D [32–50] | 0.104 | 39.64 |
WSTLTANQNPSPPWSKLTY | UL130 | F5HCP3 | 5VOB: D [28–46] | 0.138 | 33.37 |
FTYDTLRGYINRALA | UL55 | F5HB53 | 5C6T: A [486–500] | − 0.644 | 64.02 |
LRGYINRALAQIAEA | UL55 | F5HB53 | 5C6T: A [491–505] | −0.645 | 68.14 |
NRALAQIAEAWCVDQ | UL55 | F5HB53 | 5C6T: A [496–510] | −0.724 | 63.41 |
QIAEAWCVDQRRTLE | UL55 | F5HB53 | 5C6T: A [501–515] | −0.904 | 56.29 |
SAILSAIYNKPIAAR | UL55 | F5HB53 | 5C6T: A [526–540] | −1.187 | 40.75 |
SKINPSAILSAIYNK | UL55 | F5HB53 | 5C6T: A [521–535] | −1.241 | 46.13 |
VFKELSKINPSAILS | UL55 | F5HB53 | 5C6T: A [516–530] | −1.322 | 38.57 |
YAQLQFTYDTLRGYI | UL55 | F5HB53 | 5C6T: A [481–495] | −0.734 | 53.73 |
NVTFRGLQNKTEDFL | UL4 | Q6SWC6 | – | 0.442 | 19.39 |